Bioinspired large Stokes shift small molecular dyes for biomedical fluorescence imagingHao Chen, Lingjun Liu, Kun Qian et al.|Science Advances|2022 Long Stokes shift dyes that minimize cross-talk between the excitation source and fluorescent emission to improve the signal-to-background ratio are highly desired for fluorescence imaging. However, simple small molecular dyes with large Stokes shift (more than 120 nanometers) and near-infrared (NIR) emissions have been rarely reported so far. Here, inspired by the chromophore chemical structure of fluorescent proteins, we designed and synthesized a series of styrene oxazolone dyes (SODs) with simple synthetic methods, which show NIR emissions (>650 nanometers) with long Stokes shift (ranged from 136 to 198 nanometers) and small molecular weight (<450 daltons). The most promising SOD9 shows rapid renal excretion and blood-brain barrier passing properties. After functioning with the mitochondrial-targeted triphenylphosphonium (TPP) group, the resulting SOD9-TPP can be engineered for head-neck tumor imaging, fluorescence image-guided surgery, brain neuroimaging, and on-site pathologic analysis. In summary, our findings add an essential small molecular dye category to the classical dyes.
Oridonin Inhibits SARS‐CoV‐2 by Targeting Its 3C‐Like ProteaseBaisen Zhong, Weiyu Peng, Shan Du et al.|Small Science|2022 Oridonin Inhibits SARS-CoV-2 Oridonin, a natural product extracted from Rabdosia rubescens, possesses a wide range of pharmacological properties, including anti-inflammatory, anti-cancer, anti-microbial, neuroprotection, immunoregulation, etc. In article number 2100124, Baisen Zhong, Litao Sun, and co-workers demonstrate that Oridonin targets the SARS-CoV-2 3CL protease by covalently binding to cysteine145 in its active pocket to exert an anti-SARS-CoV-2 effect, which provides a novel candidate for the treatment of COVID-19.
Discovery of novel and selective SIK2 inhibitors by the application of AlphaFold structures and generative modelsWei Zhu, Xiaosong Liu, Qi Li et al.|Bioorganic & Medicinal Chemistry|2023 Discovery of Novel SIK2/3 Inhibitors for the Potential Treatment of MEF2C+ Acute Myeloid Leukemia (AML)Wei Zhu, Pei Zhao, Tingting Liu et al.|Journal of Medicinal Chemistry|2025 The dual inhibition of SIK2/3 has been considered as a potential treatment approach for MEF2C-high acute myeloid leukemia (AML). Although diverse scaffolds of pan-SIK or SIK2/3 inhibitors have been reported, few of them showed sufficient in vitro or in vivo antitumor activity. Based on the proposed binding mode of the hit molecule (7), chemical space in the solvent/P-loop region was explored via fragment growing/replacement, supported by the generative chemistry platform. Further SAR exploration and ADME optimization led to the discovery of 7s, which exhibited excellent potency and strong selectivity in MEF2C high-expression cell lines over MEF2C-low cell lines. Moreover, oral administration of 7s was found to demonstrate significant tumor growth inhibition in a MV4-11 AML mice CDX model without any body weight loss. This work highlights the potential of targeting MEF2C-dependent AML by selective oral SIK2/3 inhibitors, which was supported by the generative models.
A note on infinity norm bounds for the inverses of Nekrasov matricesZhenhua Lyu, Dan Liu, Shiyun Wang et al.|Mathematical Methods in the Applied Sciences|2024 In this paper, we present several new upper bounds for the infinity norm of the inverse of Nekrasov matrices by using scaling matrices with two values on their diagonals, which improve the corresponding results of Gao et al. and Kolotilina. Numerical examples and comparisons with the existing bounds are included.